-+ 0.00%
-+ 0.00%
-+ 0.00%

According to the Zhitong Finance App, Hanson Pharmaceuticals (03692.HK) announced that the Group's innovative drug Amelot® was successfully included in the new “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2025)” (2025 National Health Insurance Catalogue), and that all indications of Saint Roly® and Hengmu® were included in the 2025 national health insurance catalogue. The new version of the national catalogue will be officially implemented on January 1, 2026.

Zhitongcaijing·12/07/2025 23:09:01
Listen to the news
According to the Zhitong Finance App, Hanson Pharmaceuticals (03692.HK) announced that the Group's innovative drug Amelot® was successfully included in the new “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2025)” (2025 National Health Insurance Catalogue), and that all indications of Saint Roly® and Hengmu® were included in the 2025 national health insurance catalogue. The new version of the national catalogue will be officially implemented on January 1, 2026.